Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Differentiation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
| Name | Differentiation |
| Key Genes/Proteins | ACHE, ACOD1, AGING, AHR, AKT, AKT1 |
| Related Diseases | Aging, Als, Alzheimer |
| Linked Hypotheses | 1 hypotheses |
Knowledge base pages for this entity
graph TD
Differentiation["Differentiation"]
CANCER(["CANCER"])
CANCER -->|"therapeutic_target"| Differentiation
Tumor{"Tumor"}
Tumor -->|"therapeutic_target"| Differentiation
Cancer{"Cancer"}
Cancer -->|"therapeutic_target"| Differentiation
style Differentiation fill:#1a3a4a,stroke:#ffd54f,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| CANCER | activates | gene | 1.00 |
| INFLAMMATION | regulates | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| Tumor | activates | disease | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| Autoimmune | therapeutic_target | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| OVERVIEW | therapeutic_target | gene | 1.00 |
| NEURODEGENERATION | regulates | gene | 1.00 |
| CANCER | inhibits | gene | 1.00 |
| PI3K | activates | gene | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Neurodegeneration | regulates | disease | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| AKT | activates | gene | 1.00 |
| TNF | activates | gene | 1.00 |
| MTOR | therapeutic_target | gene | 1.00 |
| GENES | regulates | gene | 1.00 |
| BDNF | activates | gene | 1.00 |
| AUTOPHAGY | regulates | gene | 1.00 |
| TNF-Α | activates | gene | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| Aging | regulates | disease | 1.00 |
| MICRORNAS | regulates | gene | 1.00 |
| APOPTOSIS | regulates | gene | 1.00 |
| Cancer | regulates | disease | 1.00 |
| Tumor | regulates | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| CANCER | regulates | gene | 1.00 |
| AKT | therapeutic_target | gene | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| OXIDATIVE STRESS | regulates | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| AMPK | activates | gene | 1.00 |
| Inflammation | activates | disease | 1.00 |
| PI3K | therapeutic_target | gene | 1.00 |
| PI3K | regulates | gene | 1.00 |
| Cancer | activates | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| Als | associated_with | disease | 1.00 |
| MITOCHONDRIA | regulates | gene | 1.00 |
| ROS | activates | gene | 1.00 |
| CYTOKINES | regulates | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Partial OSK Reprogramming Reverses Epigenetic Aging Without | 0.630 | neurodegeneration | Investigate mechanisms of epigenetic rep |
| OPC differentiation blockade contributes to white matter deg | 0.599 | Alzheimer's disease | SEA-AD Single-Cell Analysis: Cell-Type V |
| Oligodendrocyte Lineage Vulnerability: Early Myelination Dis | 0.530 | neurodegeneration | Cell type vulnerability debate in Alzhei |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Anti-ASC antibody intracerebroventricular injection in APP/PS1 mice | validation | Alzheimer's disease | 0.950 | 0.00 | APP/PS1 transgenic mice (8 mon | proposed | N/A |
| PDGFRA and C-MYC protein validation in ovarian cancer tissues | exploratory | Ovarian cancer | 0.850 | 0.00 | Human ovarian cancer tissues | proposed | N/A |
| CD2AP expression and cognitive decline in AD patients | exploratory | Alzheimer's disease | 0.800 | 0.00 | human patients | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal St [PMID:41270149] | Li C, Teng T, Lin X, Sun X, Yi T et al. | Cancer Res | 2026 | 0 |
| A cellular epigenetic classification system for glioblastoma. [PMID:41499453] | Silverbush D, Jürgensen L, Freeburg NF, | Neuro Oncol | 2026 | 0 |
| Gastrointestinal Stromal Tumors: Molecular Mechanisms of Drug Resistance and Adv [PMID:41724491] | Jingnuo D, Huachuan Z, Da Z, Zhi D, Yan | J Gastroenterol Hepatol | 2026 | 0 |
| P16(+) Cells Drive Adverse Postischemic Cardiac Remodeling Through CCL8-Mediated [PMID:41766526] | Yan L, Zheng J, Lu Z, Zhu A, Ye M et al. | Circulation | 2026 | 0 |
| Multi-omics reveals heterogeneity and functional populations of oligodendrocyte [PMID:41771834] | Ye D, Zhou H, Qu S, Wang Z, Zhang F et a | Cell Death Discov | 2026 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity